{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:04:00Z","timestamp":1791947040442,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["PTCG-20-700751"],"award-info":[{"award-number":["PTCG-20-700751"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.arr.2023.102046","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T20:34:53Z","timestamp":1693254893000},"page":"102046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"91","author":[{"given":"Amish","family":"Gaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Rivet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritleen K.","family":"Bawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging\u2010Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2023.102046_bib2","series-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013"},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer\u2019s disease\u2014Lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med."},{"issue":"5","key":"10.1016\/j.arr.2023.102046_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2019.01.004","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer\u2019s disease spectrum","volume":"15","author":"Bos","year":"2019","journal-title":"Alzheimer\u2019s Dement.: J. Alzheimer\u2019s Assoc."},{"issue":"9","key":"10.1016\/j.arr.2023.102046_bib5","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer\u2019s disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimer\u2019s Dement.: J. Alzheimer\u2019s Assoc."},{"issue":"2","key":"10.1016\/j.arr.2023.102046_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1210\/clinem\/dgac580","article-title":"Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general US population","volume":"108","author":"Ciardullo","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2023.102046_bib8","article-title":"Cost-effectiveness of Alzheimer\u2019s disease CSF biomarkers and amyloid-PET in early-onset cognitive impairment diagnosis","author":"Contador","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"issue":"6","key":"10.1016\/j.arr.2023.102046_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"issue":"6","key":"10.1016\/j.arr.2023.102046_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.arr.2023.102046_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"6","key":"10.1016\/j.arr.2023.102046_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneur.57.6.808","article-title":"The preclinical phase of Alzheimer disease: A 22-year prospective study of the Framingham Cohort","volume":"57","author":"Elias","year":"2000","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.arr.2023.102046_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/bpa.12538","article-title":"Diversity of astroglial responses across human neurodegenerative disorders and brain aging","volume":"27","author":"Ferrer","year":"2017","journal-title":"Brain Pathol. (Zur., Switz. )"},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib16","first-page":"483","article-title":"Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer\u2019s disease","volume":"11","author":"Fossati","year":"2019","journal-title":"Alzheimer\u2019s Dement.: Diagn., Assess. Dis. Monit."},{"key":"10.1016\/j.arr.2023.102046_bib17","unstructured":"Fu, R., Gartlehner, G., Grant, M., Shamliyan, T., Sedrakyan, A., Wilt, T.J., Griffith, L., Oremus, M., Raina, P., Ismaila, A., Santaguida, P., Lau, J., & Trikalinos, T.A. (2008). Conducting Quantitative Synthesis When Comparing Medical Interventions: AHRQ and the Effective Health Care Program. In Methods Guide for Effectiveness and Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality (US). \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK49407\/\u3009."},{"issue":"8","key":"10.1016\/j.arr.2023.102046_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/brain\/awac407","article-title":"Brain-derived tau: a novel blood-based biomarker for Alzheimer\u2019s disease-type neurodegeneration","volume":"146","author":"Gonzalez-Ortiz","year":"2023","journal-title":"Brain: A J. Neurol."},{"key":"10.1016\/j.arr.2023.102046_bib20","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association\/american stroke association","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.arr.2023.102046_bib21","article-title":"CSF tau and \u0371-amyloid as biomarkers for mild cognitive impairment","volume":"6","author":"Hampel","year":"2004","journal-title":"Dialog-. Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.arr.2023.102046_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.arr.2023.102046_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.arr.2023.102046_bib24","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.arr.2023.102046_bib25","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease","volume":"18","author":"Hansson","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"issue":"5054","key":"10.1016\/j.arr.2023.102046_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.arr.2023.102046_bib27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4155\/bio-2019-0163","article-title":"Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood","volume":"11","author":"Hendricks","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.arr.2023.102046_bib28","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clin. Res. Ed. )"},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22179-z","article-title":"Alzheimer\u2019s disease large-scale gene expression portrait identifies exercise as the top theoretical treatment","volume":"12","author":"Hill","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.arr.2023.102046_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jnc.13399","article-title":"Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration","volume":"136","author":"Ishiki","year":"2016","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.arr.2023.102046_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.arr.2023.102046_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA\u2010AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.arr.2023.102046_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2017.00024","article-title":"Glial cells and their function in the adult brain: a journey through the history of their ablation","volume":"11","author":"J\u00e4kel","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2023.102046_bib34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fnagi.2019.00254","article-title":"Role of neurofilament light chain as a potential biomarker for Alzheimer\u2019s disease: a correlative meta-analysis","volume":"11","author":"Jin","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neurobiolaging.2013.09.035","article-title":"Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer\u2019s disease","volume":"35","author":"Kamphuis","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.arr.2023.102046_bib36","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2023.102046_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2019.100005","article-title":"Diagnostic biomarkers of Alzheimer\u2019s disease: a state-of-the-art review","volume":"1","author":"Khoury","year":"2019","journal-title":"Biomark. Neuropsychiatry"},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-200900","article-title":"Blood-based ATN biomarkers of Alzheimer\u2019s disease: a meta-analysis","volume":"79","author":"Koychev","year":"2021","journal-title":"J. Alzheimer\u2019s Dis.: JAD"},{"issue":"2","key":"10.1016\/j.arr.2023.102046_bib40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40520-021-02054-z","article-title":"Neurofilament light chain concentration in an aging population","volume":"34","author":"Ladang","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.arr.2023.102046_bib41","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.arr.2023.102046_bib42","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.arr.2023.102046_bib43","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer\u2019s Dement.: J. Alzheimer\u2019s Assoc."},{"issue":"2","key":"10.1016\/j.arr.2023.102046_bib45","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: aAn analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3233\/JAD-121384","article-title":"Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in alzheimer\u2019s disease and vascular dementia","volume":"34","author":"Olsson","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"7","key":"10.1016\/j.arr.2023.102046_bib47","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2023.102046_bib48","first-page":"700","article-title":"Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition","volume":"11","author":"Osborn","year":"2019","journal-title":"Alzheimer\u2019s Dement.: Diagn., Assess. Dis. Monit."},{"key":"10.1016\/j.arr.2023.102046_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2016.07.055","article-title":"Does mild cognitive impairment always lead to dementia? A review","volume":"369","author":"Pandya","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.arr.2023.102046_bib50","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of plasma total Tau level as a predictive biomarker for dementia and related endophenotypes","volume":"76","author":"Pase","year":"2019","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.arr.2023.102046_bib51","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1373\/clinchem.2003.030361","article-title":"Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility","volume":"50","author":"Pelsers","year":"2004","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.arr.2023.102046_bib54","doi-asserted-by":"crossref","first-page":"a020628","DOI":"10.1101\/cshperspect.a020628","article-title":"Astrocytes in neurodegenerative disease: table 1","volume":"7","author":"Phatnani","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"4","key":"10.1016\/j.arr.2023.102046_bib55","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/alz.12787","article-title":"Confounding factors of Alzheimer\u2019s disease plasma biomarkers and their impact on clinical performance","volume":"19","author":"Pichet Binette","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of Early Alzheimer\u2019s Disease: Clinical Practice in 2021","volume":"8","author":"Porsteinsson","year":"2021","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2023.102046_bib57","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neubiorev.2021.07.007","article-title":"Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"128","author":"Qu","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib58","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/jcm9010164","article-title":"Heart-type fatty acid-binding protein (H-FABP) and its role as a biomarker in heart failure: what do we know so far","volume":"9","author":"Rezar","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2023.102046_bib59","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/00002093-200307003-00003","article-title":"The increasing burden of Alzheimer disease","volume":"17","author":"Sadik","year":"2003","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"6","key":"10.1016\/j.arr.2023.102046_bib60","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuron.2018.02.015","article-title":"Tau kinetics in neurons and the human central nervous system","volume":"97","author":"Sato","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-9-10","article-title":"Overstating the evidence \u2013 double counting in meta-analysis and related problems","volume":"9","author":"Senn","year":"2009","journal-title":"BMC Med. Res. Methodol."},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib62","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"14","key":"10.1016\/j.arr.2023.102046_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025910","article-title":"Serum neurofilament light chain in patients with atrial fibrillation","volume":"11","author":"Sj\u00f6lin","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"12","key":"10.1016\/j.arr.2023.102046_bib64","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.tins.2009.08.002","article-title":"Molecular dissection of reactive astrogliosis and glial scar formation","volume":"32","author":"Sofroniew","year":"2009","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.arr.2023.102046_bib65","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3390\/ijms22042022","article-title":"The neurovascular unit dysfunction in Alzheimer\u2019s disease","volume":"22","author":"Soto-Rojas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.arr.2023.102046_bib66","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2004.07.061","article-title":"Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases","volume":"370","author":"Steinacker","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"43","key":"10.1016\/j.arr.2023.102046_bib68","doi-asserted-by":"crossref","first-page":"32679","DOI":"10.1074\/jbc.R110.135210","article-title":"Tissue-specific functions in the fatty acid-binding protein family*","volume":"285","author":"Storch","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib70","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-022-00521-3","article-title":"Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer\u2019s disease","volume":"17","author":"Visser","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.arr.2023.102046_bib71","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/brain\/awv029","article-title":"Prevalence and prognosis of Alzheimer\u2019s disease at the mild cognitive impairment stage","volume":"138","author":"Vos","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.arr.2023.102046_bib72","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"issue":"3","key":"10.1016\/j.arr.2023.102046_bib73","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment--beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J. Intern. Med."},{"issue":"8 Suppl","key":"10.1016\/j.arr.2023.102046_bib74","first-page":"S177","article-title":"Economic burden of Alzheimer disease and managed care considerations","volume":"26","author":"Wong","year":"2020","journal-title":"Am. J. Manag. Care"},{"issue":"7","key":"10.1016\/j.arr.2023.102046_bib75","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/aps.2018.37","article-title":"Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis","volume":"39","author":"Ye","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.arr.2023.102046_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt163","article-title":"Plasma tau levels in Alzheimer\u2019s disease","volume":"5","author":"Zetterberg","year":"2013","journal-title":"Alzheimer\u2019s Res. Ther."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723002052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163723002052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:17:29Z","timestamp":1761592649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163723002052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":76,"alternative-id":["S1568163723002052"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2023.102046","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2023.102046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102046"}}